Molecular Therapeutics of HBV

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|3|4|341-355

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.3, Iss.4, 2003-08, pp. : 341-355

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular diagnosis of occult HCV and HBV infections

By Michalak Tomasz I   Pham Tram NQ   Mulrooney-Cousins Patricia M  

Future Virology, Vol. 2, Iss. 5, 2007-09 ,pp. : 451-465

Future Medicine

Access to resources Recommend Favorite

Improving Cancer Therapeutics by Molecular Profiling

By  

Current Drug Metabolism, Vol. 6, Iss. 6, 2005-12 ,pp. : 553-568

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular therapeutics of myelodysplasia and myelodysplasia-related leukaemias

By Karp J.E.   Sarkodee-Adoo C.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 1, 1999-03 ,pp. : 151-163

Informa Healthcare

Access to resources Recommend Favorite

Telomerase Inhibition in Cancer Therapeutics: Molecular-Based Approaches

By  

Current Medicinal Chemistry, Vol. 13, Iss. 24, 2006-10 ,pp. : 2875-2888

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular pathophysiology and targeted therapeutics for muscular dystrophy

By Hoffman E.P.   Dressman D.  

Trends in Pharmacological Sciences, Vol. 22, Iss. 9, 2001-09 ,pp. : 465-470

Elsevier

Access to resources Recommend Favorite